ROCHESTER, Minn. — Mayo Clinic researchers collaborated on a new study led by Eli Lilly showing that the drug abemaciclib improves survival for people with high-risk, early-stage breast cancer. In the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback